{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:32:37Z","timestamp":1791253957984,"version":"4.1.0"},"reference-count":100,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.1111\/j.1743-6109.2011.02287.x","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1ZIAHL006014-01"],"award-info":[{"award-number":["1ZIAHL006014-01"]}],"id":[{"id":"10.1111\/j.1743-6109.2011.02287.x","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Priapism is a familiar problem to hematologists, well known for its association with sickle-cell disease (SCD). It also occurs in a variety of other hematological illnesses, nearly all forms of congenital hemolytic anemia, including other hemoglobinopathies and red blood cell membranopathies and enzymopathies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>Provide urologists with a comprehensive review of priapism in SCD, with an emphasis on the perspective of a practicing hematologist.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Medline searches through July 2010 were conducted using the terms priapism, erectile dysfunction, and sickle cell.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Expert opinion was based on review of the medical literature related to this subject matter.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In men with SCD, large epidemiological studies have linked the risk of priapism to clinical markers of the severity of intravascular hemolysis. Extracellular hemoglobin and arginase released during hemolysis has been implicated in reducing nitric oxide bioavailability, although the relevance of hemolysis to vascular dysfunction has been challenged by some scientists. Consistent with the role of impairment of the nitric oxide axis, mice genetically deficient in nitric oxide production have also been shown to develop priapic activity. Provocative new data indicate that hemolysis-linked dysregulation of adenosine signaling in the penis contributes to priapism in sickle cell mice. Serious questions have arisen regarding the efficacy of mainstays of textbook dogma for treatment of acute severe priapism, including intravenous fluids, alkalinization, and exchange transfusion, and there is increasing acceptance for early aspiration and irrigation of the corpus cavernosum.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>For patients with sickle cell with recurrent priapism, there is very limited evidence for a medical prophylaxis role for hydroxyurea, etilefrine, pseudoephedrine, leuprolide, sildenafil, and other agents. Recent publications have highlighted nitric oxide and adenosine signal transduction pathways as worthy of additional research. Research and clinical management of sickle-cell priapism is strengthened by multidisciplinary collaboration between hematologists and urologists.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/j.1743-6109.2011.02287.x","type":"journal-article","created":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T17:35:32Z","timestamp":1304703332000},"page":"70-78","source":"Crossref","is-referenced-by-count":42,"title":["Priapism in Sickle-Cell Disease: A Hematologist\u2019s Perspective"],"prefix":"10.1093","volume":"9","author":[{"given":"Gregory J.","family":"Kato","sequence":"first","affiliation":[{"name":"National Heart, Lung and Blood Institute, National Institutes of Health\u2014Sickle Cell Vascular Disease Section, Cardiovascular and Pulmonary Branch , Bethesda, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,1,1]]},"reference":[{"key":"2024032600332080400_bb0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archinte.1910.00050330050003","article-title":"Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia","volume":"6","author":"Herrick","year":"1910","journal-title":"Arch Intern Med"},{"key":"2024032600332080400_bb0015","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0022-5347(17)71575-3","article-title":"Priapism: Report of five cases; two occurring with sickle cell anemia","volume":"42","author":"Dawson","year":"1939","journal-title":"J Urol"},{"key":"2024032600332080400_bb0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-3476(62)80008-0","article-title":"Studies in sickle cell anemia. XIX. Priapism as a complication in children","volume":"60","author":"Sousa","year":"1962","journal-title":"J Pediatr"},{"key":"2024032600332080400_bb0025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1743-6109.2009.01625.x","article-title":"Priapism: Pathogenesis, epidemiology, and management","volume":"7","author":"Gregory","year":"2010","journal-title":"J Sex Med"},{"key":"2024032600332080400_bb0030","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1743-6109.2009.01625.x","article-title":"Priapism: Pathogenesis, epidemiology, and management","volume":"7","author":"Broderick","year":"2010","journal-title":"J Sex Med"},{"key":"2024032600332080400_bb0035","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.110.2865.543","article-title":"Sickle cell anemia, a molecular disease","volume":"109","author":"Pauling","year":"1949","journal-title":"Science"},{"key":"2024032600332080400_bb0040","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1016\/S0021-9258(17)40154-2","article-title":"Human beta-globin messenger RNA. I. Nucleotide sequences derived from complementary RNA","volume":"252","author":"Marotta","year":"1977","journal-title":"J Biol Chem"},{"key":"2024032600332080400_bb0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/mic.11.2.167.177","article-title":"Sickle cell vasoocclusion: Heterotypic, multicellular aggregations driven by leukocyte adhesion","volume":"11","author":"Frenette","year":"2004","journal-title":"Microcirculation"},{"key":"2024032600332080400_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.tracli.2008.03.013","article-title":"The alpha4beta1 integrin in sickle cell disease","volume":"15","author":"Brittain","year":"2008","journal-title":"Transfus Clin Biol"},{"key":"2024032600332080400_bb0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/01.CIR.0000044943.12533.A8","article-title":"Divergent nitric oxide bioavailability in men and women with sickle cell disease","volume":"107","author":"Gladwin","year":"2003","journal-title":"Circulation"},{"key":"2024032600332080400_bb0060","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1182\/blood.V97.6.1584","article-title":"Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation","volume":"97","author":"Belhassen","year":"2001","journal-title":"Blood"},{"key":"2024032600332080400_bb0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ajh.10387","article-title":"Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels","volume":"74","author":"Eberhardt","year":"2003","journal-title":"Am J Hematol"},{"key":"2024032600332080400_bb0070","doi-asserted-by":"crossref","first-page":"H1799","DOI":"10.1152\/ajpheart.2000.278.6.H1799","article-title":"Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse","volume":"278","author":"Kaul","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2024032600332080400_bb0075","doi-asserted-by":"crossref","first-page":"R1949","DOI":"10.1152\/ajpregu.2000.279.6.R1949","article-title":"Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease","volume":"279","author":"Nath","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2024032600332080400_bb0080","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1182\/blood.V88.6.2311.bloodjournal8862311","article-title":"Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: Potential role in sickle cell disease","volume":"88","author":"Setty","year":"1996","journal-title":"Blood"},{"key":"2024032600332080400_bb0085","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2141.2005.05701.x","article-title":"Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality","volume":"130","author":"Kato","year":"2005","journal-title":"Br J Haematol"},{"key":"2024032600332080400_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00277-003-0610-8","article-title":"Erythropoiesis and serum sVCAM-1 levels in adults with sickle cell disease","volume":"82","author":"Duits","year":"2003","journal-title":"Ann Hematol"},{"key":"2024032600332080400_bb0095","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/ajh.20129","article-title":"Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea","volume":"76","author":"Conran","year":"2004","journal-title":"Am J Hematol"},{"key":"2024032600332080400_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2007.06740.x","article-title":"Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability","volume":"139","author":"Ataga","year":"2007","journal-title":"Br J Haematol"},{"key":"2024032600332080400_bb0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10739680490278402","article-title":"The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy","volume":"11","author":"Hebbel","year":"2004","journal-title":"Microcirculation"},{"key":"2024032600332080400_bb0110","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.2008.598","article-title":"Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy","volume":"300","author":"Kato","year":"2008","journal-title":"JAMA"},{"key":"2024032600332080400_bb0115","first-page":"55","article-title":"Priapism in a 15-year-old boy with major beta-thalassemia","volume":"5","author":"Ziaee","year":"2008","journal-title":"Urol J"},{"key":"2024032600332080400_bb0120","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ajh.21110","article-title":"Hemoglobin-E beta thalassemia presenting with recurrent priapism\u2014A rare complication","volume":"83","author":"Sharma","year":"2008","journal-title":"Am J Hematol"},{"key":"2024032600332080400_bb0125","first-page":"523","article-title":"Priapism in thalassemia intermedia","volume":"76","author":"Dore","year":"1991","journal-title":"Haematologica"},{"key":"2024032600332080400_bb0130","first-page":"486","article-title":"Thalassemia intermedia and recurrent priapism following splenectomy","volume":"75","author":"Macchia","year":"1990","journal-title":"Haematologica"},{"key":"2024032600332080400_bb0135","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/bjs.1800730832","article-title":"Recurrent priapism following splenectomy for thalassaemia intermedia","volume":"73","author":"Jackson","year":"1986","journal-title":"Br J Surg"},{"key":"2024032600332080400_bb0140","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/bjs.1800731236","article-title":"Priapism and thalassaemia intermedia","volume":"73","author":"Rao","year":"1986","journal-title":"Br J Surg"},{"key":"2024032600332080400_bb0145","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1538-7836.2008.03024.x","article-title":"Delayed adverse vascular events after splenectomy in hereditary spherocytosis","volume":"6","author":"Schilling","year":"2008","journal-title":"J Thromb Haemost"},{"key":"2024032600332080400_bb0150","first-page":"3702","article-title":"Stuttering priapism associated with hereditary spherocytosis","volume":"14","author":"Prabhakaran","year":"2007","journal-title":"Can J Urol"},{"key":"2024032600332080400_bb0155","first-page":"394","article-title":"[Paroxysmal nocturnal hemoglobinuria and priapism]","volume":"87","author":"Montalban","year":"1986","journal-title":"Med Clin (Barc)"},{"key":"2024032600332080400_bb0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajh.10374","article-title":"Priapism in a patient with unstable hemoglobin: Hemoglobin Koln","volume":"74","author":"Andrieu","year":"2003","journal-title":"Am J Hematol"},{"key":"2024032600332080400_bb0165","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/sj.thj.6200104","article-title":"Acute priapism in a patient with unstable hemoglobin Perth and Factor V Leiden under effective oral anticoagulant therapy","volume":"2","author":"Gyan","year":"2001","journal-title":"Hematol J"},{"key":"2024032600332080400_bb0170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/(SICI)1096-8652(199602)51:2<133::AID-AJH6>3.0.CO;2-Z","article-title":"Priapism following splenectomy in an unstable hemoglobin: Hemoglobin Olmsted beta 141 (H19) Leu\u2013&gt;Arg","volume":"51","author":"Thuret","year":"1996","journal-title":"Am J Hematol"},{"key":"2024032600332080400_bb0175","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1111\/j.1743-6109.2008.01007.x","article-title":"Glucose-6-phosphate dehydrogenase deficiency associated stuttering priapism: Report of a case","volume":"5","author":"Finley","year":"2008","journal-title":"J Sex Med"},{"key":"2024032600332080400_bb0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1743-6109.2007.00631.x","article-title":"Glucose-6-phosphate dehydrogenase deficiency: An etiology for idiopathic priapism?","volume":"5","author":"Burnett","year":"2008","journal-title":"J Sex Med"},{"key":"2024032600332080400_bb0185","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0022-5347(17)59030-8","article-title":"Priapism caused by glucose phosphate isomerase deficiency","volume":"116","author":"Goulding","year":"1976","journal-title":"J Urol"},{"key":"2024032600332080400_bb0190","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-5347(05)65458-4","article-title":"Priapism in a 15-year-old boy with congenital dyserythropoietic anemia type II (hereditary erythroblastic multinuclearity with positive acidified serum lysis test)","volume":"167","author":"Edney","year":"2002","journal-title":"J Urol"},{"key":"2024032600332080400_bb0195","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0090-4295(92)90393-B","article-title":"Priapism associated with asplenic state","volume":"40","author":"Atala","year":"1992","journal-title":"Urology"},{"key":"2024032600332080400_bb0200","first-page":"1084","article-title":"Post-splenectomy veno-occlusive priapism in a child with idiopathic thrombocytopenic purpura","volume":"4","author":"Gross","year":"2002","journal-title":"Isr Med Assoc J"},{"key":"2024032600332080400_bb0205","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2141.2008.07155.x","article-title":"Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy","volume":"142","author":"Westerman","year":"2008","journal-title":"Br J Haematol"},{"key":"2024032600332080400_bb0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","article-title":"Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes","volume":"21","author":"Kato","year":"2007","journal-title":"Blood Rev"},{"key":"2024032600332080400_bb0215","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2141.2009.08004.x","article-title":"Pleiotropic effects of intravascular haemolysis on vascular homeostasis","volume":"148","author":"Kato","year":"2010","journal-title":"Br J Haematol"},{"key":"2024032600332080400_bb0220","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"2024032600332080400_bb0225","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.freeradbiomed.2008.01.008","article-title":"Sickle cell disease vasculopathy: A state of nitric oxide resistance","volume":"44","author":"Wood","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"2024032600332080400_bb0230","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension and mortality in sickle cell disease","volume":"294","author":"Morris","year":"2005","journal-title":"JAMA"},{"key":"2024032600332080400_bb0235","doi-asserted-by":"crossref","first-page":"15215","DOI":"10.1073\/pnas.221292098","article-title":"Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease","volume":"98","author":"Aslan","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024032600332080400_bb0240","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood.V78.10.2753.2753","article-title":"Hydroxyl radical formation by sickle erythrocyte membranes: Role of pathologic iron deposits and cytoplasmic reducing agents","volume":"78","author":"Repka","year":"1991","journal-title":"Blood"},{"key":"2024032600332080400_bb0245","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI110724","article-title":"Spontaneous oxygen radical generation by sickle erythrocytes","volume":"70","author":"Hebbel","year":"1982","journal-title":"J Clin Invest"},{"key":"2024032600332080400_bb0250","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bcmd.2010.02.005","article-title":"Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype","volume":"44","author":"Landburg","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"2024032600332080400_bb0255","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2141.2009.07658.x","article-title":"Endogenous nitric oxide synthase inhibitors in sickle cell disease: Abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death","volume":"145","author":"Kato","year":"2009","journal-title":"Br J Haematol"},{"key":"2024032600332080400_bb0260","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2141.2006.06074.x","article-title":"Sickle cell leg ulcers: Associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta\/BMP pathway","volume":"133","author":"Nolan","year":"2006","journal-title":"Br J Haematol"},{"key":"2024032600332080400_bb0265","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N Engl J Med"},{"key":"2024032600332080400_bb0270","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMra0804411","article-title":"Pulmonary complications of sickle cell disease","volume":"359","author":"Gladwin","year":"2008","journal-title":"N Engl J Med"},{"key":"2024032600332080400_bb0275","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood-2010-02-268193","article-title":"Pulmonary hypertension and nitric oxide depletion in sickle cell disease","volume":"116","author":"Bunn","year":"2010","journal-title":"Blood"},{"key":"2024032600332080400_bb0280","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.blre.2007.10.002","article-title":"Advances in the diagnosis and therapy of paroxysmal nocturnal hemoglobinuria","volume":"22","author":"Brodsky","year":"2008","journal-title":"Blood Rev"},{"key":"2024032600332080400_bb0285","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1743-6109.2008.00770.x","article-title":"Sickle cell disease status and outcomes of African-American men presenting with priapism","volume":"5","author":"Bennett","year":"2008","journal-title":"J Sex Med"},{"key":"2024032600332080400_bb0290","first-page":"234","article-title":"Outcome of management of acute prolonged priapism in patients with homozygous sickle cell disease","volume":"28","author":"Adetayo","year":"2009","journal-title":"West Afr J Med"},{"key":"2024032600332080400_bb0295","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1464-410X.1986.tb09008.x","article-title":"Priapism: A three-phase concept of management according to aetiology and prognosis","volume":"58","author":"Pohl","year":"1986","journal-title":"Br J Urol"},{"key":"2024032600332080400_bb0300","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0022-5347(17)41904-5","article-title":"Experience with 105 patients with priapism: Update review of all aspects","volume":"140","author":"Winter","year":"1988","journal-title":"J Urol"},{"key":"2024032600332080400_bb0305","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00043426-199911000-00013","article-title":"Prevalence of priapism in children and adolescents with sickle cell anemia","volume":"21","author":"Mantadakis","year":"1999","journal-title":"J Pediatr Hematol Oncol"},{"key":"2024032600332080400_bb0310","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000206316","article-title":"Priapism in association with sickle cell anemia in Saudi Arabia","volume":"73","author":"Al-Awamy","year":"1985","journal-title":"Acta Haematol"},{"key":"2024032600332080400_bb0315","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0140-6736(90)90419-6","article-title":"Comparison of homozygous sickle cell disease in northern Greece and Jamaica","volume":"335","author":"Christakis","year":"1990","journal-title":"Lancet"},{"key":"2024032600332080400_bb0320","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1182\/blood-2005-04-1594","article-title":"Hemolysis-associated priapism in sickle cell disease","volume":"106","author":"Nolan","year":"2005","journal-title":"Blood"},{"key":"2024032600332080400_bb0325","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"key":"2024032600332080400_bb0330","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2133.2007.08323.x","article-title":"Sickle cell leg ulcers: A frequently disabling complication and a marker of severity","volume":"158","author":"Halabi-Tawil","year":"2008","journal-title":"Br J Dermatol"},{"key":"2024032600332080400_bb0335","first-page":"157","article-title":"Haematological parameters associated with priapism in Nigerian patients with homozygous sickle cell disease","volume":"91","author":"Adedeji","year":"1988","journal-title":"J Trop Med Hyg"},{"key":"2024032600332080400_bb0340","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0002-9343(93)90061-S","article-title":"Multisystem damage associated with tricorporal priapism in sickle cell disease","volume":"94","author":"Sharpsteen","year":"1993","journal-title":"Am J Med"},{"key":"2024032600332080400_bb0345","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1365-2141.2004.05295.x","article-title":"Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia","volume":"128","author":"Nolan","year":"2005","journal-title":"BrJ Haematol"},{"key":"2024032600332080400_bb0350","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2141.2007.06560.x","article-title":"Genetic polymorphisms associated with priapism in sickle cell disease","volume":"137","author":"Elliott","year":"2007","journal-title":"Br J Haematol"},{"key":"2024032600332080400_bb0355","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tracli.2008.03.012","article-title":"Sickle red cell adhesion: Many issues and some answers","volume":"15","author":"Kaul","year":"2008","journal-title":"Transfus Clin Biol"},{"key":"2024032600332080400_bb0360","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0407183102","article-title":"Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism","volume":"102","author":"Champion","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024032600332080400_bb0365","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1172\/JCI33467","article-title":"Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling","volume":"118","author":"Mi","year":"2008","journal-title":"J Clin Invest"},{"key":"2024032600332080400_bb0370","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1111\/j.1743-6109.2009.01552.x","article-title":"Adenosine deaminase enzyme therapy prevents and reverses the heightened cavernosal relaxation in priapism","volume":"7","author":"Wen","year":"2010","journal-title":"J Sex Med"},{"key":"2024032600332080400_bb0375","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1096\/fj.09-144147","article-title":"Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling","volume":"24","author":"Wen","year":"2010","journal-title":"FASEB J"},{"key":"2024032600332080400_bb0380","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/j.1939-4640.2002.tb02601.x","article-title":"Noncholinergic penile erection in mice lacking the gene for endothelial nitric oxide synthase","volume":"23","author":"Burnett","year":"2002","journal-title":"J Androl"},{"key":"2024032600332080400_bb0385","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1073\/pnas.030419997","article-title":"Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice","volume":"97","author":"Hedlund","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024032600332080400_bb0390","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1111\/j.1743-6109.2009.01359.x","article-title":"Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism","volume":"6","author":"Bivalacqua","year":"2009","journal-title":"J Sex Med"},{"key":"2024032600332080400_bb0395","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1111\/j.1743-6109.2009.01337.x","article-title":"Increased cavernosal relaxations in sickle cell mice priapism are associated with alterations in the NO-cGMP signaling pathway","volume":"6","author":"Claudino","year":"2009","journal-title":"J Sex Med"},{"key":"2024032600332080400_bb0400","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1096\/fj.09-144147","article-title":"Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling","volume":"24","author":"Wen","year":"2010","journal-title":"FASEB J"},{"key":"2024032600332080400_bb0405","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-5347(17)38248-4","article-title":"Priapism associated with the sickle cell hemoglobinopathies: Prevalence, natural history and sequelae","volume":"145","author":"Fowler","year":"1991","journal-title":"J Urol"},{"key":"2024032600332080400_bb0410","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.hoc.2005.08.003","article-title":"Priapism in sickle cell disease","volume":"19","author":"Rogers","year":"2005","journal-title":"Hematol Oncol Clin N Am"},{"key":"2024032600332080400_bb0415","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S1481803500013609","article-title":"Myth: Blood transfusion is effective for sickle cell anemia-associated priapism","volume":"8","author":"Merritt","year":"2006","journal-title":"CJEM"},{"key":"2024032600332080400_bb0420","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajh.20142","article-title":"Follow-up of sickle cell disease patients with priapism treated by hydroxyurea","volume":"77","author":"Saad","year":"2004","journal-title":"Am J Hematol"},{"key":"2024032600332080400_bb0425","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1097\/00005392-199805000-00065","article-title":"Hydroxyurea in the treatment of sickle cell associated priapism","volume":"159","author":"Al Jam\u2019a","year":"1998","journal-title":"J Urol"},{"key":"2024032600332080400_bb0430","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1743-6109.2006.00333.x","article-title":"Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism","volume":"3","author":"Burnett","year":"2006","journal-title":"J Sex Med"},{"key":"2024032600332080400_bb0435","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0002-9343(02)01165-8","article-title":"Sildenafil relieves priapism in patients with sickle cell disease","volume":"113","author":"Bialecki","year":"2002","journal-title":"Am J Med"},{"key":"2024032600332080400_bb0440","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0022-5347(17)35520-9","article-title":"Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism","volume":"150","author":"Levine","year":"1993","journal-title":"J Urol"},{"key":"2024032600332080400_bb0445","first-page":"167","article-title":"Successful treatment of stutter priapism with an antiandrogen","volume":"4","author":"Costabile","year":"1998","journal-title":"Tech Urol"},{"key":"2024032600332080400_bb0450","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(85)91555-7","article-title":"Stilboestrol and stuttering priapism in homozygous sickle-cell disease","volume":"2","author":"Serjeant","year":"1985","journal-title":"Lancet"},{"key":"2024032600332080400_bb0455","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ajh.10069","article-title":"Short period of administration of diethylstilbestrol in stuttering priapism in sickle cell anemia","volume":"69","author":"Gbadoe","year":"2002","journal-title":"Am J Hematol"},{"key":"2024032600332080400_bb0460","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00000441-197210000-00005","article-title":"Priapism in sickle cell disease: Report of five cases","volume":"264","author":"Karayalcin","year":"1972","journal-title":"Am J Med Sci"},{"key":"2024032600332080400_bb0465","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-5347(17)65545-9","article-title":"Priapism in sickle cell anemia: Treatment by estrogenic hormone","volume":"84","author":"Erman","year":"1960","journal-title":"J Urol"},{"key":"2024032600332080400_bb0470","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1046\/j.1365-2141.2002.03691.x","article-title":"Etilefrine for the prevention of priapism in adult sickle cell disease","volume":"118","author":"Okpala","year":"2002","journal-title":"Br J Haematol"},{"key":"2024032600332080400_bb0475","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/adc.85.1.52","article-title":"Management of sickle cell priapism with etilefrine","volume":"85","author":"Gbadoe","year":"2001","journal-title":"Arch Dis Child"},{"key":"2024032600332080400_bb0480","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood.V95.1.78","article-title":"Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anemia and prolonged priapism","volume":"95","author":"Mantadakis","year":"2000","journal-title":"Blood"},{"key":"2024032600332080400_bb0485","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0022-5347(17)35817-2","article-title":"Association of sickle cell disease, priapism, exchange transfusion and neurological events: ASPEN syndrome","volume":"150","author":"Siegel","year":"1993","journal-title":"J Urol"},{"key":"2024032600332080400_bb0490","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3476(05)81954-7","article-title":"Neurologic events after partial exchange transfusion for priapism in sickle cell disease","volume":"120","author":"Rackoff","year":"1992","journal-title":"J Pediatr"},{"key":"2024032600332080400_bb0495","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9 years of treatment","volume":"289","author":"Steinberg","year":"2003","journal-title":"JAMA"},{"key":"2024032600332080400_bb0500","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"Am J Hematol"},{"key":"2024032600332080400_bb0505","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1111\/j.1743-6109.2009.01285.x","article-title":"Oral phosphodiesterase type 5 inhibitors alleviate recurrent priapism complicating thalassemia intermedia: A case report","volume":"6","author":"Tzortzis","year":"2009","journal-title":"J Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515337048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515337048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/1\/70\/47770280\/jsm_9_1_70.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/9\/1\/70\/47770280\/jsm_9_1_70.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T01:27:21Z","timestamp":1711416441000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/9\/1\/70\/6886830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,1]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,1]]},"published-print":{"date-parts":[[2012,1,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02287.x","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,1]]},"published":{"date-parts":[[2012,1,1]]}}}